Stocks › CORT
CORCEPT THERAPEUTICS INC
CORT·Nasdaq·
United States·USD
United States·USD$119.60
+0.03 (+0.03%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
CORT
CORCEPT THERAPEUTICS INC · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CORTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CORT by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 James B. RenacciHouse · R · OH |
CORTCORCEPT THERAPEUTICS INC · Stock |
Sale $15,001 - $50,000 |
Dec 21, 2017 | Dec 15, 2017 | Filing ↗ |
| James B. RenacciHouse · R · OH |
CORTCORCEPT THERAPEUTICS INC · Stock |
Purchase $1,001 - $15,000 |
Dec 6, 2017 | Nov 20, 2017 | Filing ↗ |
| James B. RenacciHouse · R · OH |
CORTCORCEPT THERAPEUTICS INC · Stock |
Purchase $1,001 - $15,000 |
Oct 18, 2017 | Oct 11, 2017 | Filing ↗ |
Whale Activity
Position changes in CORT reported for 2026-06-30 by 11 tracked institutional filers
- Increased4
- New0
- Held0
- Decreased5
- Closed1
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 12.4M | $1.08B | increased |
| RENAISSANCE TECHNOLOGIES LLC | 5.3M | $457.5M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $438.6M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | $362.8M | increased |
| D. E. Shaw & Co., Inc. | 883.0K | $76.8M | decreased |
| TWO SIGMA INVESTMENTS, LP | 610.1K | $53.0M | decreased |
| MILLENNIUM MANAGEMENT LLC | 152.6K | $13.3M | decreased |
| CITADEL ADVISORS LLC | 109.1K | $9.5M | decreased |
| Bridgewater Associates, LP | 57.6K | $5.0M | increased |
| S&T BANK/PA | 55.6K | $4.8M | — |
| Point72 Asset Management | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CORT insiders, by quarter · Form 4
Recent Insider Transactions
1,924 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −5,147 | $116.58 | $600K | Oct 2, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −2,086 | $115.73 | $241K | Oct 2, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −1,100 | $114.52 | $126K | Oct 2, 2026 | Form 4 ↗ |
| Lyon Joseph DouglasSee Remarks | Sale | −4,744 | $116.54 | $553K | Oct 2, 2026 | Form 4 ↗ |
| Lyon Joseph DouglasSee Remarks | Sale | −4,446 | $115.70 | $514K | Oct 2, 2026 | Form 4 ↗ |
| Maduck SeanSee Remarks | Sale | −8,744 | $116.55 | $1.0M | Oct 2, 2026 | Form 4 ↗ |
| Maduck SeanSee Remarks | Sale | −15.8K | $116.12 | $1.8M | Oct 2, 2026 | Form 4 ↗ |
| Lyon Joseph DouglasSee Remarks | Sale | −810 | $115.40 | $93K | Oct 1, 2026 | Form 4 ↗ |
| Maduck SeanSee Remarks | Sale | −413 | $115.54 | $48K | Oct 1, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −296 | n/c | — | Sep 16, 2026 | Form 4 ↗ |
| WILSON JAMES NDirector · Director | Sale | −6,800 | $110.27 | $750K | Sep 15, 2026 | Form 4 ↗ |
| WILSON JAMES NDirector · Director | Sale | −400 | $110.84 | $44K | Sep 15, 2026 | Form 4 ↗ |
| WILSON JAMES NDirector · Director | Sale | −2,800 | $111.70 | $313K | Sep 15, 2026 | Form 4 ↗ |
| Lyon Joseph DouglasSee Remarks | Sale | −7,812 | $113.32 | $885K | Sep 14, 2026 | Form 4 ↗ |
| Lyon Joseph DouglasSee Remarks | Sale | −2,188 | $114.12 | $250K | Sep 14, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −974 | $112.40 | $109K | Sep 2, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −5,621 | $114.58 | $644K | Sep 2, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −23.8K | $110.70 | $2.6M | Sep 2, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −23.6K | $109.35 | $2.6M | Sep 2, 2026 | Form 4 ↗ |
| Vieira Roberto WandenkolkPresident, Oncology | Sale | −1,606 | $113.72 | $183K | Sep 2, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CORT · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 5.8M | $500.3M | 0.45% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.9M | $251.6M | 0.01% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.1M | $182.0M | 0.10% | Jun 30, 2026 |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 1.8M | $157.5M | 5.60% | Jun 30, 2026 |
| Fidelity Contrafund | 1.3M | $114.6M | 0.06% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.2M | $104.9M | 0.22% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.1M | $95.3M | 0.10% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF SPDR SERIES TRUST | 876.5K | $76.2M | 0.45% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF iShares Trust | 858.6K | $74.7M | 0.91% | Jun 30, 2026 |
| VANGUARD TAX-MANAGED SMALL-CAP FUND VANGUARD TAX-MANAGED FUNDS | 615.8K | $53.5M | 0.47% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list CORT's shares (CUSIP 218352102), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CORCEPT THERAPEUTICS INC as client
No lobbying filings found naming CORCEPT THERAPEUTICS INC as the client.
Government Contracts
Federal awards to CORCEPT THERAPEUTICS INC · USAspending
No federal contract awards found for CORCEPT THERAPEUTICS INC.
U.S. Patents
Recent USPTO applications naming CORCEPT THERAPEUTICS INC
No USPTO patent applications found for CORCEPT THERAPEUTICS INC.
Annual Financials
From CORT's 10-K filings · XBRL
No annual XBRL figures on record for CORT. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CORT's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureSep 23, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 29, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 17, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJun 3, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteMay 28, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsDec 31, 2025
EDGAR ↗
About CORCEPT THERAPEUTICS INC
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersREDWOOD CITY, CA
IncorporatedDE
SEC CIK0001088856 ↗